2 completed, 1 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
Follow Ensure Plus: new trials by email Literature Review of Ensure Plus trials Research Report on Ensure Plus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Predictive Methods & Product Performance in Healthy Adults for Pediatric Patients, A Case Study: Furosemide Water, Parmalat⢠Whole Milk, Similac Pro-Advance⢠- Medication Absorption | Phase 1 | Withdrawn | Yale University | 2018-12-31 | 2019-01-18 | |
| A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI) Ensure Plus, Pancrelipase in combination with Ensure Plus - Exocrine Pancreatic Insufficiency, Pancreatitis, Chronic | Phase 1 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 13 | 2008-07-01 | 2011-05-19 |
| Gastric and Intestinal Satiation in Obese and Normal Weight Healthy People ensure plus, standardized test meal - Endocrine System Diseases | Phase 1 | Completed | University Hospital, Basel, Switzerland | 65 | 2007-01-01 | 2011-10-20 |
Cerebral Palsy (1) · Endocrine System Diseases (1) · Exocrine Pancreatic Insufficiency (1) · Pancreatitis (1) · Pancreatitis, Chronic (1) · Steatorrhea (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · University Hospital, Basel, Switzerland (1) · Yale University (1)
Switzerland (1) · United States (1)
Christoph Beglinger, MD (1) · Jeffrey Testani, MD (1)